Takeda Is Close to Selling Emerging Market, European Drugs
The Takeda Pharmaceutical Co. logo is displayed at the company’s global headquarters in Tokyo, Japan. (Photographer: Kentaro Takahashi/Bloomberg)

Takeda Is Close to Selling Emerging Market, European Drugs

(Bloomberg) -- Takeda Pharmaceutical Co. is close to selling some assets in emerging markets and western Europe, people familiar with the matter said, a move that would help the Japanese drugmaker ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.